159 related articles for article (PubMed ID: 37516310)
1. NETosis Is Induced by Complement Component 5a: Implications in the Pathogenesis of Pyoderma Gangrenosum.
Wang Z; Hornick N; Vague M; Yang D; Keller J; Kody S; Leachman S; Ortega-Loayza AG; Liu Y
J Invest Dermatol; 2024 Jan; 144(1):184-188.e2. PubMed ID: 37516310
[No Abstract] [Full Text] [Related]
2. Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1.
Lu JD; Milakovic M; Ortega-Loayza AG; Marzano AV; Alavi A
Expert Opin Investig Drugs; 2020 Nov; 29(11):1179-1185. PubMed ID: 32880206
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum.
Croia C; Dini V; Loggini B; Manni E; Romanelli M; Migliorini P
Exp Dermatol; 2021 Sep; 30(9):1340-1344. PubMed ID: 34057268
[TBL] [Abstract][Full Text] [Related]
4. Pyoderma gangrenosum in a patient with essential thrombocythemia.
King KW; Murray A
J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
[TBL] [Abstract][Full Text] [Related]
5. [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].
Trémezaygues L; Schmaltz R; Vogt T; Reichrath J
Hautarzt; 2010 Apr; 61(4):345-53; quiz 354-5. PubMed ID: 20361320
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.
Wu BC; Patel ED; Ortega-Loayza AG
Br J Dermatol; 2017 Jul; 177(1):72-83. PubMed ID: 27864925
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
Dasanu CA; Bockorny B; Alexandrescu DT
J Oncol Pharm Pract; 2015 Dec; 21(6):471-3. PubMed ID: 24986794
[TBL] [Abstract][Full Text] [Related]
8. [PATHOGENESIS OF PYODERMA GANGRENOSUM].
JABLONSKA S
Hautarzt; 1964 Nov; 15():584-91. PubMed ID: 14345917
[No Abstract] [Full Text] [Related]
9. [Lung involvement in pyoderma gangrenosum: a case report and review of the literature].
Batalla A; Pérez-Pedrosa A; García-Doval I; González-Barcala FJ; Rosón E; de la Torre C
Actas Dermosifiliogr; 2011 Jun; 102(5):373-7. PubMed ID: 21397890
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum with pulmonary involvement?
Liu ZH; Lu XL; Fu MH; Zhang GY; Liu WD
Eur J Dermatol; 2008; 18(5):583-5. PubMed ID: 18693166
[TBL] [Abstract][Full Text] [Related]
11. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
Shenefelt PD
Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibitors-associated pyoderma gangrenosum, a systematic review of published case reports.
Khoshnam-Rad N; Gheymati A; Jahangard-Rafsanjani Z
Anticancer Drugs; 2022 Jan; 33(1):e1-e8. PubMed ID: 34282745
[TBL] [Abstract][Full Text] [Related]
13. Familial ulcerative pyoderma gangrenosum: a report of 2 kindred.
Alberts JH; Sams HH; Miller JL; King LE
Cutis; 2002 Jun; 69(6):427-30. PubMed ID: 12078842
[TBL] [Abstract][Full Text] [Related]
14. Vegetative pyoderma gangrenosum.
Kim RH; Lewin J; Hale CS; Meehan SA; Stein J; Ramachandran S
Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526339
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum: a clinical manifestation of difficult diagnosis.
Santos M; Talhari C; Rabelo RF; Schettini AP; Chirano CA; Talhari S
An Bras Dermatol; 2011; 86(1):153-6. PubMed ID: 21437541
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of pyoderma gangrenosum (PG): an updated review.
Braswell SF; Kostopoulos TC; Ortega-Loayza AG
J Am Acad Dermatol; 2015 Oct; 73(4):691-8. PubMed ID: 26253362
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of pyoderma gangrenosum: case report and review.
Alam M; Grossman ME; Schneiderman PI; Blume RS; Benvenisty AI
Dermatol Surg; 2000 Nov; 26(11):1063-6. PubMed ID: 11096397
[TBL] [Abstract][Full Text] [Related]
18. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
19. Recurrent pyoderma gangrenosum precipitated by breast cancer: a case report and review of the literature.
Duchnowska R; Ziajka E; Góralska A; Grala B
J Med Case Rep; 2014 Jun; 8():226. PubMed ID: 24965126
[TBL] [Abstract][Full Text] [Related]
20. PYODERMA GANGRENOSUM AS THE PRESENTING SIGN OF REGIONAL ILEITIS: OBSERVATIONS REGARDING THE PATHOGENESIS OF THE SKIN LESIONS.
BISHOPRIC GA; BRACKEN JS
South Med J; 1964 Jun; 57():675-8. PubMed ID: 14157441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
